Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

被引：0
|
作者：
Elalfy, Mohsen Saleh [1 ]
Hassan, Tamer [2 ]
Elsayh, Khalid [3 ]
Maebid, Mohamed [4 ]
Hassab, Hoda [5 ,6 ]
Elashry, Rasha [7 ]
El Ghamrawy, Mona [8 ]
Elhawy, Mahmoud [9 ]
Zakaria, Marwa [10 ]
Elshanshory, Mohamed [11 ]
机构：
[1] Ain Shams Univ, Cairo, Egypt
[2] Zagazig Univ, Zagazig, Egypt
[3] Assiut Univ, Assiut, Egypt
[4] Bany Soif Univ, Bany Soif, Egypt
[5] Alexandria Univ, Paediat Dept, Fac Med, Alexandria, Egypt
[6] Alexandria Univ, Clin Res Ctr, Fac Med, Alexandria, Egypt
[7] Mansoura Univ, Mansoura, Egypt
[8] Cairo Univ, Cairo, Egypt
[9] Menoufia Univ, Menoufia, Egypt
[10] Zagazig Univ, Zagazig, Egypt
[11] Tanta Univ, Tanta, Egypt
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-121994
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4907
引用
收藏
页数：3
相关论文
共 50 条
  • [21] ELTROMBOPAG SAFETY AND EFFICACY IN OLDER THAN 65 YEARS OLD PRIMARY IMMUNE THROMBOCYTOPENIA PATIENTS IN CLINICAL PRACTICE
    Gonzalez-Lopez, T. J.
    Alvarez-Roman, M. T.
    Hernandez-Rivas, J. A.
    Perez-Rus, G.
    Pascual, C.
    Bernat, S.
    Fernandez-Fuentes, F.
    Sanchez-Gonzalez, B.
    Andrade, M. M.
    Jarque, I.
    Olivera, P. E.
    Martinez-Robles, V.
    Gomez-Nunez, M.
    Fernandez-Rodriguez, A.
    Cortes, M.
    Fuertes-Palacio, M. A.
    Fisac, R.
    Penarrubia, M. J.
    Aguilar, C.
    Barez, A.
    De Cabo, E.
    Fernandez-Minano, C.
    Gonzalez-Porras, J. R.
    Garcia-Frade, L. J.
    HAEMATOLOGICA, 2016, 101 : 592 - 592
  • [22] Effectiveness and Safety of Statin Therapy in Children: A Multi-Center, Real-World Clinical Practice Experience
    Kavey, Rae Ellen W.
    Manlhiot, Cedric
    Collins, Tanveer
    Gidding, Samuel S.
    Demczko, Matthew
    Clauss, Sarah
    Phillippi, Ruth
    Harahsheh, Ashraf
    Mietus-Snyder, Michele
    McCrindle, Brian
    CIRCULATION, 2015, 132
  • [23] Romiplostim for the treatment of adults with primary Immune Thrombocytopenia (ITP) in routine clinical practice in Germany - Interim results from an observational study (PLATEAU)
    Welstau, M.
    Reiser, M.
    Illmer, T.
    Schlag, R.
    Josten, K.
    Dietzfelbinger, H.
    Tschechne, B.
    Schaffrik, M.
    Soelch, J-P
    ONKOLOGIE, 2012, 35 : 223 - 223
  • [24] Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France - Interim Results From a Large Observational Study
    Quittet, Philippe
    Hamidou, Mohamed
    Bonnotte, Bernard
    Fain, Olivier
    Dillingham, Kerry
    Kreuzbauer, Georg
    BLOOD, 2012, 120 (21)
  • [25] ROMIPLOSTIM FOR THE TREATMENT OF ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS FROM A LARGE, EUROPEAN, OBSERVATIONAL STUDY
    Wadenvik, H.
    Steurer, M.
    Janssens, A.
    Quittet, P.
    Kaiafa, G.
    Kozak, T.
    Papadaki, H.
    Selleslag, D.
    Dillingham, K.
    Kreuzbauer, G.
    HAEMATOLOGICA, 2012, 97 : 252 - 252
  • [26] Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice - Interim Results From a Large, European, Observational Study
    Selleslag, Dominik
    Janssens, Ann
    Wadenvik, Hans
    Steurer, Michael
    Quittet, Philippe
    Kaiafa, Georgia
    Kozak, Tomas
    Papadaki, Helen
    Viallard, Jean-Francois
    Dillingham, Kerry
    Kreuzbauer, Georg
    BLOOD, 2012, 120 (21)
  • [27] UPDATED RESULTS FROM A LARGE, OBSERVATIONAL STUDY OF PATIENTS (PTS) WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) RECEIVING ROMIPLOSTIM IN EUROPEAN CLINICAL PRACTICE
    Papadaki, H.
    Janssens, A.
    Kaiafa, G.
    Kozak, T.
    Selleslag, D.
    Steurer, M.
    Quittet, P.
    Viallard, J. F.
    Wadenvik, H.
    Belton, L.
    Kreuzbauer, G.
    HAEMATOLOGICA, 2014, 99 : 203 - 203
  • [28] Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
    Khellaf, Mehdi
    Michel, Marc
    Quittet, Philippe
    Viallard, Jean-Francois
    Alexis, Magda
    Roudot-Thoraval, Francoise
    Cheze, Stephane
    Durand, Jean-Marc
    Lefrere, Francois
    Galicier, Lionel
    Lambotte, Olivier
    Panelatti, Gerard
    Slama, Borhane
    Damaj, Gandhi
    Sebahoun, Gerard
    Gyan, Emmanuel
    Delbrel, Xavier
    Dhedin, Nathalie
    Royer, Bruno
    Schleinitz, Nicolas
    Rossi, Jean-Francois
    Mahevas, Matthieu
    Languille, Laetitia
    Bierling, Philippe
    Godeau, Bertrand
    BLOOD, 2011, 118 (16) : 4338 - 4345
  • [29] PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia An observational, nonintervention study of real-life practice
    Mihaylov, Georgi
    Skopec, Barbara
    Sninska, Zuzana
    Tzvetkov, Nikolai
    Cerna, Olga
    Ivanushkin, Vladlen
    Niepel, Daniela
    Bjorklof, Katja
    Cernelc, Peter
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (02) : 227 - 234
  • [30] Generic romiplostim for children with persistent or chronic immune thrombocytopenia: Experience from a tertiary care centre in North India
    Mareddy, Chandana
    Kalra, Manas
    Sachdeva, Anupam
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (05) : 618 - 626
12345